About Obagi Medical Products (NASDAQ:OMPI)
Obagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Obagi sells its products through a direct sales force in the United States and internationally through distribution partners in over 43 countries across North America, Central America, Europe, the Middle East and Asia. In April 2013, Valeant Pharmaceuticals International Inc acquired the entire share capital of Obagi Medical Products Inc.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Obagi Medical Products (NASDAQ:OMPI) Frequently Asked Questions
What is Obagi Medical Products' stock symbol?
Obagi Medical Products trades on the NASDAQ under the ticker symbol "OMPI."
Who are some of Obagi Medical Products' key competitors?
Some companies that are related to Obagi Medical Products include Roche (ROG), Sanofi (SAN), Bayer (BAYN), CSL (CSL), GlaxoSmithKline (GSK), AstraZeneca (AZN), Beximco Pharmaceuticals (BXP), Shire (SHP), Fresenius Medical Care (FMS), Essilor International Société Anonyme (EI), Ramsay Health Care (RHC), Medivation (MDVN), Hologic (HOLX), Merck KGaA (MRK), Smith & Nephew (SN), Teleflex (TFX), AEGON (AGN) and Henry Schein (HSIC).
How do I buy Obagi Medical Products stock?
Shares of Obagi Medical Products can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Obagi Medical Products?
Obagi Medical Products' mailing address is 50 Technology Drive, IRVINE, CA 92618, United States. The specialty pharmaceutical company can be reached via phone at +1-562-6281007.
MarketBeat Community Rating for Obagi Medical Products (OMPI)MarketBeat's community ratings are surveys of what our community members think about Obagi Medical Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Obagi Medical Products (NASDAQ:OMPI) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Obagi Medical Products (NASDAQ:OMPI) Earnings History and Estimates Chart
Obagi Medical Products (NASDAQ OMPI) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/14/2013||Q4 2012||$0.21||$0.15||$30.06 million||$30.30 million||View||Listen|
|11/1/2012||Q312||$0.20||$0.22||$28.87 million||$29.10 million||View||N/A|
Obagi Medical Products (NASDAQ:OMPI) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Obagi Medical Products (NASDAQ:OMPI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Obagi Medical Products (NASDAQ OMPI)
No insider trades for this company have been tracked by MarketBeat.com
Obagi Medical Products (NASDAQ OMPI) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Obagi Medical Products (NASDAQ:OMPI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Obagi Medical Products (NASDAQ:OMPI) Income Statement, Balance Sheet and Cash Flow Statement
Obagi Medical Products (NASDAQ OMPI) Stock Chart for Tuesday, December, 12, 2017